期刊文献+

人脐静脉血管内皮细胞在体移植替代猴角膜内皮细胞的形态学分析 被引量:3

Microstructure observation of human vascular endothelial cells transplantation in autograft to replace monkey corneal endothelial cells
暂未订购
导出
摘要 目的使用去除后弹力层的恒河猴自体角膜为细胞载体,将培养的人脐静脉血管内皮细胞(human umbilical vein endothelial cells,HUVEC)种植到角膜内表面,观察HUVEC替代恒河猴角膜内皮细胞的功能情况以及HUVEC在恒河猴眼内生长的情况。方法取恒河猴6只随机分为3组:实验组(3只)、实验对照组(2只)、空白对照组(1只)。实验组:用离心沉淀法将培养的HUVEC移植到去除后弹力层的恒河猴自体角膜内表面,之后将自体角膜缝回植床;实验对照组:将撕除部分后弹力层的术眼角膜植片原位缝回植床;空白对照组:取下术眼角膜植片不做任何处理原位缝回植床。术后观察各组角膜植片透明情况;实验组及实验对照组于术后30 d及60 d、空白对照组于术后60 d行术眼摘除,标本做病理切片、CD34免疫组化及扫描电镜,观察房角结构及HUVEC在角膜植片内表面形态分布。结果实验组角膜植片维持了一定的厚度和透明性,而实验对照组角膜植片发生严重大泡性改变。病理切片示实验组角膜内表面可见一层细胞生长,CD34染色阳性,提示为血管内皮细胞;实验对照组角膜内表面未见任何细胞生长;空白对照组角膜植片保留完整后弹力层及内皮细胞层。扫描电镜示实验组有HUVEC单层在角膜内表面生长但有大量白细胞聚集及少量细胞碎片嵌顿于小梁网;实验对照组角膜内表面残留胶原纤维样物质,无细胞生长;空白对照组见完整六边形角膜内皮细胞层。结论 HUVEC能够在撕除后弹力层的恒河猴角膜内表面生长并发挥一定的屏障作用,维持角膜的厚度和透明性,但会产生较重的排斥反应。 Objective Using the Descemet's membrane-removed rhesus autologous corneal as the cell carrier and transplant the cultured human umbilical vein endothelial cells( HUVEC) to the inner surface of the cornea,to observe the function of HUVEC after alternative rhesus monkey corneal endothelial cell and the growth of the HUVEC in the rhesus monkey eye corneal surface.Methods The experimented monkeys were divided into 3 groups: experimental group( 3 cases),experimental control group( 2 cases) and blank control group( 1 case). In experimental group,cultured HUVEC were transplanted onto rhesus monkey posterior corneal surface without corneal endothelium; In experimental control group,the detached corneal Descemet membrane of rhesus monkey fixed in suit without cultured HUVEC transplantation; In blank control group,a simple penetrativity corneal transplantation without destroy the descemet membrane performed. The transparent of implants in each group was observed after corneal transplantation. Histopathology of cornea grafts,immunohistochemistry and scanning electron microscope were performed at 30 days and 60 days postoperatively in order to observe the appearance of HUVEC onto the monkey posterior corneal surface and the structure of anterior chamber angle. Results The corneal implants of experimental group kept transparency and thickness in some extent while the experimental control group showed severity corneal edema and bullae. Histopathology of corneal grafts showed that a cells layer with CD34 staining positive reaction growth on posterior corneal surface of corneal button in the experimental group,which indicated that the layer of cells were HUVEC,no cell and material like membrane could be seen on that of the experimental control group; A layer of corneal endothelial cells and Descemet's membrane were visible on that of the blank control group.Scanning electron microscope showed that a layer of HUVEC were growing on the posterior surface of cornea button with plenty of leucocytes and small amounts of cell debris could be found to block up the trabecula meshwork,collagen fibers remained on the posterior surface of cornea button of the experimental control group with no cell grown; The complete corneal endothelial cells layer with six-fringe shape could be found in the blank control group. Conclusion HUVEC can survive and enduce the barrier function at the posterior surface of rhesus monkey cornea without corneal endothelial cells,and keep the cornea button transparency and normal thickness in some extent,but severe rejection will happen.
出处 《眼科新进展》 CAS 北大核心 2014年第11期1020-1024,共5页 Recent Advances in Ophthalmology
基金 2013年云南省科技厅昆明医科大学应用基础研究联合专项(编号:2013FB109)~~
关键词 血管内皮细胞 角膜内皮细胞 恒河猴 vascular endothelium cell corneal endothelium cell rhesus monkey
  • 相关文献

参考文献20

  • 1Shimmura S, Miyashita H, Konomi K, Shinozaki N, Taguchi T, Kobayashi H. Transplantation of corneal endothelium with Descemet' s membrane using a hyroxyethyl methacrylate polymer as a carrier[ J]. Br J Ophthalmol,2005,89(14) :134-137.
  • 2Terry MA, Ousley PJ, Will B. A practical femtoseeond laser pro- cedure for DLEK endothelial transplantation :cadaver eye histol- ogy and topography [ J ]. Cornea, 2005,24 (4) :453 -459.
  • 3Ishino Y, Sano Y, Nakamura T, Connon CJ, Rigby H, Nigel J. Amniotic membrane as a carrier for cultivated human corneal endo- thelial cell transplantation [ J ]. Invest Ophthalmol Vis Sci, 2004,45 ( 2 ) : 800-806.
  • 4徐志强,齐鹏,杨晓庆,杜志敏,李万里.干细胞在中枢神经系统疾病治疗中的应用[J].新乡医学院学报,2013,30(1):71-74. 被引量:9
  • 5Terry MA, Ousley PJ. Deep lamellar endothelial keratoplasty in the first United States patients:early clinical results[J]. Corne- a,2001,20(3) :239-243.
  • 6Gorovoy MS. Deseemet-Stripping automated endothelial kerato- plasty [ J ]. Cornea ,2006,25 (8) :886-889.
  • 7Shin JS,Jang IK, Kim CW, Kim JC. Development and character- ization of a rabbit corneal endothelial cell line [ J ]. Jpn J Ophthaimol,2004,48 (5) :454-459.
  • 8Joo CK,Green WR,Pepose JS,Fleming TP. Repopulation of denuded murine Descemet' s membrane with life-extended routine corneal endothelial cells as a model for corneal cell transplantation[J]. Graefes Arch Clin Eev Ophthalmol,2000,238 ( 2 ) : 174- 180.
  • 9Chen D,Zhang LH, Pang B,Chen J,Xu ZN,Abe I. FKS06 matura- tion involves a cytochrome P450 protein-catalyzed four-electron C-9 oxidation in parallel with a C-31 o-methylation[J]. Bavteriol,2013,195(14) :1931 - 1939.
  • 10Andrew W,David G. Somatostatin is an immunosuppressive factor in aqueous humor [ J ]. Invest Ophthalmol Vis Sci, 2003,44 ( 1 ) :2544-2546.

二级参考文献36

  • 1Vivanco I,Sawyers CL. The phosphatidylinositol 3-kinase Akt pathway in human cancer[J].Nature Reviews Cancer,2002,(07):489-501.
  • 2Gao X,Lowry PR,Zhou X. PI3K/Akt signaling requires spatial compartment alization in plasma membrane mircodomains[J].Proceedings of the National Academy of Sciences(USA),2011,(35):14509-14514.
  • 3Mcauliffe PF,Meric-Bemstam F,Mills GB. Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis[J].Clinical Breast Cancer,2010,(Suppl 3):59-65.
  • 4Goodman CA,Miu MH,Frey JW. A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy[J].Molecular Biology of the Cell,2010,(18):3258-3268.
  • 5Inoki K,Li Y,Zhu T. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling[J].Nature Cell Biology,2002,(09):648-657.doi:10.1038/ncb839.
  • 6Walker EH,Pacold ME,Perisic O. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin,LY294002,quercetin,myricetin,and staurosporine[J].Molecules and Cells,2000,(04):909-919.
  • 7Pahnke J,Wolkenhauer O,Krohn M. Clinico-pathologic function of cerebral ABC transporters-implications for the pathogenesis of Alzheimer's disease[J].Current Alzheimer Research,2008,(04):396-405.
  • 8Lindvall O,Kokaia Z. Stem cells for the treatment of neurological disorders[J].Nature,2006,(7097):1094-1096.
  • 9Tuszynski M H,Thal L,Pay M. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease[J].Nature Medicine,2005,(05):551-555.
  • 10Newman M B,Bakay R A. Therapeutic potentials of human embryonic stem cells in Parkinson' s disease[J].Neurotherapeutics,2008,(02):237-251.

共引文献12

同被引文献52

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部